Lucid Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LUCD and other ETFs, options, and stocks.

About LUCD

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. 

CEO
Lishan Aklog
CEOLishan Aklog
Employees
72
Employees72
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2018
Founded2018
Employees
72
Employees72

LUCD Key Statistics

Market cap
122.55M
Market cap122.55M
Price-Earnings ratio
-0.84
Price-Earnings ratio-0.84
Dividend yield
Dividend yield
Average volume
853.29K
Average volume853.29K
High today
$1.03
High today$1.03
Low today
$0.9495
Low today$0.9495
Open price
$1.01
Open price$1.01
Volume
729.19K
Volume729.19K
52 Week high
$1.80
52 Week high$1.80
52 Week low
$0.7201
52 Week low$0.7201

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own LUCD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.